Vivek Subbiah, Executive Medical Director of Novel Therapies and Clinical Trial Network at Stanford Health Care, shared a post on LinkedIn:
“Hot off the press. Our latest piece is live today in Cell Press journal Trends in Cancer.
We break down the evolution of precision oncology and reimagine what comes next: moving beyond single-target thinking to truly integrated molecular medicine.”
Title: Beyond one gene, one target: Next-generation precision oncology
Authors: Vivek Subbiah, Razelle Kurzrock
Read the Full Article on Trends in Cancer
